Medicus Pharma Ltd. (MDCXW) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Medicus Pharma Ltd. (MDCXW:NASDAQ), powered by AI.

Current Price
$0.68
Sector
Healthcare
What is the Medicus Pharma Ltd. stock price forecast?

Medicus Pharma Ltd. is currently trading at $0.68. View real-time AI analysis on Alpha Lenz.

What is Medicus Pharma Ltd. insider trading activity?

View the latest insider trading data for Medicus Pharma Ltd. on Alpha Lenz.

What is Medicus Pharma Ltd.'s P/E ratio?

View Medicus Pharma Ltd.'s valuation metrics on Alpha Lenz.

Medicus Pharma Ltd.

NASDAQ · MDCXW
$0.68+0.00(+0.00%)Pre-marketNASDAQ regular session 09:30–16:00 ET
Ask about Medicus Pharma Ltd.'s future dividend policy...
Alpha Chat Insight

Medicus Pharma Ltd.'s ROE is -2311.2%. Explore profitability and growth together.

Ask for details

Company Overview

Medicus Pharma Ltd. operates as a biotechnology and pharmaceutical company focused on the research, development, and commercialization of innovative medical treatments. The company's primary aim is to develop therapies that address unmet medical needs, particularly in the areas of oncology, neurology, and infectious diseases. Medicus Pharma Ltd. is recognized for its robust pipeline of novel drug candidates and its commitment to advancing medicine through pioneering R&D efforts. A significant aspect of Medicus Pharma's operations is the use of cutting-edge technology and collaborative partnerships with academic institutions and other pharmaceutical entities to bring advanced solutions to market. The company plays a critical role in the healthcare sector by contributing to medical innovation and improving patient outcomes globally. Medicus Pharma Ltd. holds an influential position in the financial market due to its strategic focus on high-demand therapeutic areas and its potential for breakthroughs that can transform patient care. As a participant in the biotechnology and pharmaceutical sectors, the company is pivotal in driving health-related advancements and offering investment exposure to the fast-evolving life sciences industry.

CEODr. Raza Bokhari M.B.A., M.D., MBA
SectorHealthcare
IndustryDrug Manufacturers - General
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
$0.00Revenue
0.00Shares Out
0Employees

Margins

N/AGross
N/AEBITDA
N/AOperating
N/APre-Tax
N/ANet

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-451.28%ROA
-2311.22%ROE
-437.47%ROIC

Financial Health

$8.71MCash & Cash Equivalents
$1.32MNet Debt
26866.25%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Medicus Pharma Ltd. (ticker: MDCXW) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - General).

The current price is $0.68 with a P/E ratio of -x and P/B of -x.

ROE is -2311.22%.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Medicus Pharma Ltd. (MDCXW) Stock Forecast 2026 $0.68 — Price, Financials & Analyst Targets | Alpha Lenz